Search Menu
Photonics Media Photonics Buyers' Guide Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook
More News

Blue light and platinum fight cancer

Facebook Twitter LinkedIn Email Comments
Blue light could become a big cancer killer by activating what could be a powerful platinum-based treatment.

A research team led by the University of Warwick, with researchers at Ninewells Hospital Dundee and the University of Edinburgh, has discovered a new platinum-based light-activated compound that is up to 80 times more powerful than other platinum-based anti-cancer drugs. In addition, this compound is stable and much more targeted than similar treatments, and it is water-soluble, so the body can simply dissolve and flush it after use.

The team had previously found a UV-activated platinum-based compound, but the narrowness of the UV wavelength would have limited its use. But the new compound, known as trans,trans,trans-[Pt(N3)2(OH)2(py)2], can be activated by visible blue or even green light.

It was tested at the hospital on cultivated esophageal cancer cells. Once stimulated by blue light, the compound was highly effective, killing 50 percent of the cancer cells with a concentration of just 8.4 μmol per liter. The researchers are also beginning to examine the compound’s effectiveness against ovarian and liver cancer cells.

The results of the current study were published in Angewandte Chemie International Edition, Vol. 49, Issue 47, pp. 8905-8908, Nov. 15, 2010.

Feb 2011
Angewandte Chemie International EditionBiophotonicsBioScanblue lightcancerCancer Cellscancer researchEuropeNewsNinewells Hospital Dundeeplatinumplatinum-based compoundUKUniversity of EdinburghUniversity of WarwickUV activation

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.